Lv3
204 积分 2024-09-20 加入
Structure-Based Discovery of HS34: A Highly Selective and Orally Bioavailable CDK9 Inhibitor for Triple-Negative Breast Cancer
17天前
已完结
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer
22天前
已完结
Discovery of Small-Molecule Degraders of the CDK9-Cyclin T1 Complex for Targeting Transcriptional Addiction in Prostate Cancer
22天前
已完结
Escin enhanced the efficacy of sorafenib by autophagy‐mediated apoptosis in lung cancer cells
26天前
已完结
Is it feasible for CDKs inhibitors to herald a new era in tackling the low sensitivity and drug resistance associated with PARP inhibitors?
2个月前
已关闭
20-HETE: Its potential role in physiological and pathophysiological processes
2个月前
已完结
Design, synthesis and biological evaluation of dehydroabietic acid derivative as potent vasodilatory agents
2个月前
已完结
Discovery of chalcone-1,2,4-triazole derivatives with potent anti-tumor activity targeting Bcl-2: In vitro and in vivo evaluation
2个月前
已完结
Avermectin induces P-glycoprotein expression in S2 cells via the calcium/calmodulin/NF-κB pathway
2个月前
已完结
Beyond Inhibition: Recent Advances of Heterobifunctional Molecules Targeting CDK9
2个月前
已完结
皖公网安备34019202002308
